Reuters logo
BRIEF-Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma
March 27, 2017 / 12:15 PM / 7 months ago

BRIEF-Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma

March 27 (Reuters) - Delcath Systems Inc

* Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below